DiaMedica Therapeutics Inc banner

DiaMedica Therapeutics Inc
NASDAQ:DMAC

Watchlist Manager
DiaMedica Therapeutics Inc Logo
DiaMedica Therapeutics Inc
NASDAQ:DMAC
Watchlist
Price: 7.72 USD -2.89% Market Closed
Market Cap: $402.1m

Wall Street
Price Targets

DMAC Price Targets Summary
DiaMedica Therapeutics Inc

Wall Street analysts forecast DMAC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DMAC is 15.81 USD with a low forecast of 11.11 USD and a high forecast of 26.25 USD.

Lowest
Price Target
11.11 USD
44% Upside
Average
Price Target
15.81 USD
105% Upside
Highest
Price Target
26.25 USD
240% Upside
DiaMedica Therapeutics Inc Competitors:
Price Targets
MRVL
Marvell Technology Group Ltd
29% Upside
PTCT
PTC Therapeutics Inc
35% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-65%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-65%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DMAC's stock price target?
Price Target
15.81 USD

According to Wall Street analysts, the average 1-year price target for DMAC is 15.81 USD with a low forecast of 11.11 USD and a high forecast of 26.25 USD.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett